Tech Company Financing Transactions
Modulo Bio Funding Round
Bioverge, BuildersVC and Cantos Ventures participated in a $8 million funding round for Modulo Bio. The round was announced on 6/1/2023.
Transaction Overview
Company Name
Announced On
6/1/2023
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the development of its first therapeutic program and its Modulo Neuroimmune Platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6195 Cornerstone Court East 105
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Undisclosed
Website
Email Address
Overview
Modulo Bio is a biotech startup.We reprogram the brain's immune system to overcome the world's toughest diseases
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mike Horowitz
Chief Technical Officer
Scott Patterson
Co-Founder
Justin Ichida
Browse more venture capital transactions:
Prev: 6/1/2023: MindsDB venture capital transaction
Next: 6/1/2023: Pixxel venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs